Reducing stigma for people who inject drugs living with HIV in Malaysia
Reducing Stigma in People Who Inject Drugs with HIV Using a Rapid Start Antiretroviral Therapy Intervention
This study is working to help people in Malaysia who inject drugs and are living with HIV by making it easier for them to get treatment and reducing the stigma they face in healthcare settings, so they can receive better care and support.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10885208 on NIH RePORTER |
What this research studies
This research focuses on addressing the stigma faced by people who inject drugs (PWID) living with HIV in Malaysia, a country where HIV incidence is rising among this vulnerable population. The study aims to implement a rapid start antiretroviral therapy intervention designed to improve access to treatment and reduce discrimination in healthcare settings. By utilizing behavioral design interventions, the research seeks to change how healthcare providers perceive and treat PWID, ultimately improving their health outcomes. The approach includes innovative strategies like nudges and choice architecture to encourage non-discriminatory practices among medical professionals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and are living with HIV in Malaysia.
Not a fit: Patients who do not inject drugs or are not living with HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to HIV treatment for PWID, reducing stigma and enhancing their overall health and well-being.
How similar studies have performed: Previous research has shown that stigma-reducing interventions can be effective, but this approach using behavioral design is relatively novel and untested in this specific context.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Altice, Frederick Lewis — Yale University
- Study coordinator: Altice, Frederick Lewis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.